Medicare Drug Price Negotiation Results: 2027

Today, the Centers for Medicare and Medicaid Services (CMS) released the results from the Medicare Drug Price Negotiation Program for Initial Price Applicability Year (IPAY) 2027 (press release). What was the average reduction in drug prices? Across the 15 drugs included in the 2027 negotiation, on average, drug prices fell by 62% (median: 63%); accounting…

Read More

Abbott’s $23B Bet on Exact Sciences: Bold Move or Risky Gamble?

Abbott’s $23 billion acquisition of Exact Sciences positions the company to become a major player in cancer diagnostics. Experts think the deal makes strategic sense, as it offers higher margins and a broader commercial scale — but questions remain about long-term growth amid rising competition and the challenges of integrating a patient-focused, tech-heavy business. The…

Read More

The Opportunity being Missed in UK Healthcare Buyouts

Following Brexit, the funding infrastructure for new buyout funds in the UK has broken down. These new managers are now struggling to find anchor investors and offer an opportunity to the private sector to step in and secure attractive returns. The post The Opportunity being Missed in UK Healthcare Buyouts appeared first on MedCity News.

Read More